🔎 Trials Near Me

መነሻ › ግሊዎብላስቶማ › ካሊፎርኒያ

በካሊፎርኒያ ለግሊዎብላስቶማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለግሊዎብላስቶማ የሚደረጉ 40 ጥናቶች በካሊፎርኒያ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በካሊፎርኒያ ውስጥ ያሉ ከተሞች

Official study text (English)

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

  • City of Hope Comprehensive Cancer Center, Duarte
  • UC San Diego Moores Cancer Center, La Jolla
  • Los Angeles General Medical Center, Los Angeles
  • እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT05432804

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

  • University of California, San Diego, La Jolla
  • Cedars Sinai - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
  • St. Joseph Hospital, Orange
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT03970447

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

  • Kaiser Permanente, Los Angeles
  • UCLA, Los Angeles
  • Sutter Health - California Pacific Medical Center, San Francisco
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT05902169

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • UCSD Moores Cancer Center, La Jolla
  • Cedars-Sinai Medical Center, Los Angeles
  • Stanford University, Palo Alto
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07326566

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM

  • University of California San Diego, San Diego
  • University of California San Francisco, San Francisco
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT05303467

Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma

  • University of California Davis Comprehensive Cancer Center, Sacramento
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07145112

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Children's Hospital Los Angeles, Los Angeles
  • University of California at Los Angeles, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እስከ እድሜ 25 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT04094610

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Precision NextGen Oncology, Beverly Hills
  • OPN Healthcare, Inc, Glendale
  • University of Southern California, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06047379

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

  • Cedars-Sinai Medical Center, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT04977375

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT07089641

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT07452458

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

  • City of Hope - Duarte Cancer Center, Duarte
  • UCLA Health Bowyer Oncology Center, Los Angeles
  • UCSF Helen Diller Medical Center at Parnassus Heights - Neurology, San Francisco
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06914128

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

  • University of California, Los Angeles (Data Collection Only), Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06934889

Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

  • City of Hope Medical Center, Duarte
  • Standford University, Stanford
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT05139056

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

  • City of Hope Comprehensive Cancer Center, Duarte
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UC San Diego Moores Cancer Center, La Jolla
  • እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT06860594

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • University of California San Diego, La Jolla
  • University of California, Los Angeles, Los Angeles
  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT05303519

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

  • Cedars-Sinai Medical Center, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT06319027

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

  • University of California, San Francisco, San Francisco
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኦገስ 2026 · NCT06186401

Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas

  • City of Hope Medical Center, Duarte
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT07544992

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, San Francisco, San Francisco
  • Pacific Neuroscience Institute / Saint John's Cancer Institute, Santa Monica
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦገስ 2026 · NCT05708352

A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial

  • University of California, San Francisco, San Francisco
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ31 ጁላይ 2026 · NCT06069726

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

  • City of Hope, Duarte
  • HOAG, Newport Beach
  • UCSF, San Francisco
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ጁላይ 2026 · NCT06805305

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

  • City of Hope Medical Center, Duarte
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT06815029

Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer

  • City of Hope Medical Center, Duarte
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁን 2026 · NCT07664579

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

  • University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁን 2026 · NCT04678648

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

  • University of California, San Francisco, San Francisco
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ2 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ11 ጁን 2026 · NCT04732065

PH Sensitive MRI Based Resections of Glioblastoma

  • Ronald Reagan Medical Center, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሜይ 2026 · NCT06176066

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • Beckman Research Institute of City of Hope, Duarte
  • VA Medical Center, Fresno, Fresno
  • Santa Clara Valley Medical Center, Fruitdale
  • እና 5 ተጨማሪ
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ኤፕሪ 2026 · NCT05297734

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • University of California, Irvine, Irvine
  • University of California Los Angeles, Los Angeles
  • University of California at San Francisco, San Francisco
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT06810544

Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ማርች 2026 · NCT07461948

Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ኖቬም 2025 · NCT06090903

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Duarte
  • Massive Bio SYNERGY-AI site, Irvine
  • Massive Bio SYNERGY-AI site, La Jolla
  • እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

  • University of California at Los Angeles, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ኦክቶ 2025 · NCT06059690

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

  • Cedars Sinai Medical Center, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2025 · NCT05941507

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

  • Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ጁን 2025 · NCT03175224

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

  • University of California, San Francisco, San Francisco
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ28 ፌብሩ 2024 · NCT06283927

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

  • University of California, San Francisco, San Francisco
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እስከ እድሜ 90 · ሁሉም ጾታዎች · የተሻሻለው በ22 ፌብሩ 2024 · NCT06273176

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

  • University of California, San Francisco (UCSF), San Francisco
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ22 ፌብሩ 2024 · NCT06118723

The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)

  • University of California, San Francisco, San Francisco
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ27 ኖቬም 2023 · NCT06146738

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

  • University of California, San Francisco, San Francisco
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ27 ኖቬም 2023 · NCT06146725

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።